Actual Medicinal Product (AMP) Ramipril 5mg tablets (Mawdsley-Brooks & Company Ltd)
This product can't be added to an MCA list.
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Moisture sensitive medicines. Store in airtight (sealed) container. Stability study shows moisture sensitivity but supports use in MCAs for up to 2 months.
- Provenance
-
This recommendation is based on the products Tritace 5mg tablets (SANOFI) and Ramipril 5mg (Zentiva).
- Generic
- Ramipril
- Formulation
- Ramipril 5mg tablets
-
Ramipril
-
Ramipril 5mg tablets
-
Ramipril 5mg tablets (Mawdsley-Brooks & Company Ltd)
-
-